ArcticZymes AS has established ArcticZymes Inc. as a wholly owned subsidiary located in Plymouth Meeting, PA. The company will be providing cold adapted and heat-labile unique enzymes for the research and molecular diagnostics market in North America.

"The formation of a U.S. based subsidiary is a key milestone for our company and our B2B and OEM customers in North America. Our intention is to facilitate our end users' research by providing access to our products and technical support in an effective and productive manner," said Jan Buch Andersen, Managing Director of ArcticZymes AS. 

 "Our enzymes originate from cold-living organisms in the Arctic Sea north of Norway. We offer unique solutions for contamination control, and eliminate sample loss through heat-inactivation as opposed to removing the enzyme through extraction. For our customers the absence of sample loss and unique contamination degrading properties of ArcticZymes enzymes means better signal to noise ratios and better consistency in the research and diagnostic PCR field", says Andersen.

ArcticZymes AS has partnered with Percorso Life Sciences, LLC in Plymouth Meeting, PA to aide in the implementation and execution of the organizations' operations and strategy in North America.

ArcticZymes Inc. is an operating entity as of today, and will provide customer service, technical sales, technical support, and product logistics to ArcticZymes' customers in North America from Jan 12, 2012.

distribué par

Ce noodl a été diffusé par Biotec Pharmacon ASA et initialement mise en ligne sur le site http://www.biotec.no. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-11 14:37:02 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.